A. Abrishami, J. Ho, J. Wong, L. Yin and F. Chung, Sugammadex, “A Selective Reversal Medication for Preventing Postoperative Residual Neuromuscular Blockade,” Anasthesia & Analgesia, Vol. 110, 2010, p. 1239.

has been cited by the following article:

• TITLE: Successful Use of Sugammadex in a Myasthenic Patient Case Report

  AUTHORS: Silvia Kangassu Rios, Daiana Gomes, Marcos Lopes De Miranda, Carlos Frederico La Cava, Carlos Darcy Bersot

  KEYWORDS: Sugammadex; Myasthenia Gravis; Rocuronium; Neuromuscular Monitoring; Anesthesia

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.3 No.1, January 31, 2013

  ABSTRACT: The Myasthenia gravis (MG) is an autoimmune disease that affects neuromuscular transmission and leads to a large variation of sensibility on depolarizing and nondepolarizing neuromuscular blocking drugs. Sugammadex is a new drug with the capability to successfully revert the nondepolarizing neuromuscular blocking. This case report will show a patient with MG that was scheduled for thymectomy, with the objective to use sugammadex to reverse a rocuronium induced deep level of neuromuscular block and observing the safe use of sugammadex without complications.